Start of Coverage: 29-03-2022
We are revising slightly downwards our numbers resulting in a FY 2023-2024e revision vs our previous figures of: i) 0% in revenues, ii) 0% in EBITDA, iii) -3%-0% in net profit while leaving our target valuation unchanged. We are upgrading to Outperform on valuation grounds.
Analyst: Juan Ros-Padilla
e-mail: juan.ros-padilla@oddo-bhf.com
| Analyst | Price target | Recommendation | Date |
| Juan Ros-Padilla | 24.50 € | Outperform | 23 Mar 2023 |
| Juan Ros-Padilla | 24.50 € | Neutral | 13 Jan 2023 |
| Isabel Carballo | 21.70 € | Neutral | 29 Mar 2022 |
The information presented refers to recommendations issued by analysts that follow the Jerónimo Martins share. For more information, please read the Analysts Coverage section in this website’s Terms and Conditions.